Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Muscle spasms, Pain, Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: Dose number=3; injection-site soreness; radiating pain up neck; migraine; fatigue; chills; sweats; arthralgia (esp in knees); leg and foot cramping; tingling in injection arm for 1 day; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Dec2021 15:00 (Lot number: F51620) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hemiplegic migraines" (unspecified if ongoing), notes: Known verbatim: Hemiplegic migraines. Concomitant medication(s) included: PROBIOTICS; PRILOSEC [OMEPRAZOLE]. Past drug history included: Demerol, reaction(s): "Known allergy: Demerol", notes: Known allergy: Demerol. Vaccination history included: Bnt162b2 (Previous dose details:, Prev dose product: COVID-19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose Lot number: ER8730, Prev dose dose number: 1, Prev dose vaccine location: Right arm), administration date: 10Apr2021, when the patient was 47 years old, for COVID-19 immunization, reaction(s): "injection-site soreness", "radiating pain up neck", "lymph node swelling", "migraine", "Fatigue"; Bnt162b2 (Previous dose details:, Prev dose product: COVID-19, Prev dose brand: Pfizer, Prev dose brand unknown: False, Prev dose Lot number:EW0185,, Prev dose dose number: 2, Prev dose vaccine location: Right arm), administration date: 08May2021, when the patient was 47 years old, for COVID-19 Immunization, reaction(s): "injection-site soreness", "radiating pain up neck", "lymph node swelling", "migraine", "Fatigue". The following information was reported: IMMUNISATION (non-serious) with onset 13Dec2021 15:00, outcome "unknown", described as "Dose number=3"; VACCINATION SITE PAIN (non-serious) with onset Dec2021, outcome "not recovered", described as "injection-site soreness"; PAIN (non-serious) with onset Dec2021, outcome "not recovered", described as "radiating pain up neck"; MIGRAINE (non-serious) with onset Dec2021, outcome "not recovered", described as "migraine"; FATIGUE (non-serious) with onset Dec2021, outcome "not recovered", described as "fatigue"; CHILLS (non-serious) with onset Dec2021, outcome "not recovered", described as "chills"; HYPERHIDROSIS (non-serious) with onset Dec2021, outcome "not recovered", described as "sweats"; ARTHRALGIA (non-serious) with onset Dec2021, outcome "not recovered", described as "arthralgia (esp in knees)"; MUSCLE SPASMS (non-serious) with onset Dec2021, outcome "not recovered", described as "leg and foot cramping"; VACCINATION SITE PARAESTHESIA (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "tingling in injection arm for 1 day". Therapeutic measures were not taken as a result of vaccination site pain, pain, migraine, fatigue, chills, hyperhidrosis, arthralgia, muscle spasms, vaccination site paraesthesia.  No follow-up attempts are possible. No further information is expected.